Skip to content

The CONTINUUM project: Coordination of Long-Term Rehabilitation for Indigenous Patients to Improve Quality of Life and Outcomes

Coordination of Long-Term Rehabilitation for Indigenous Patients to Improve Quality of Life and Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000577314
Acronym
The CONTINUUM project
Enrollment
300
Registered
2026-05-07
Start date
2026-07-01
Completion date
2027-07-01
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This randomised, open-label, intervention study aims to implement culturally appropriate coordination for personalised rehabilitation programs over and above the usual pathways of care for Aboriginal and Torres Strait Islander people returning to the community following a heart, stroke or diabetes-related hospitalisation at the Royal Adelaide Hospital. Aboriginal Australians face an epidemic of chronic disease and a significant gap in total disease burden compared to non-Aboriginal Australians. Rehabilitation is key to managing chronic diseases, reducing mortality, unnecessary re-hospitalisations and healthcare costs. The study aims to recruit 300 Aboriginal or Torres Strait Islander adults who are hospitalised with chronic disease and referred to specialised rehabilitation. Eligible participants will be randomised to receive 12-months of coordinated care for their individualised rehabilitation plan (intervention) or usual care (control). The study will determine whether coordinated care for rehabilitation plans improve the receipt of evidence-based healthcare and quality of life for Aboriginal people with chronic disease.

Interventions

Participants in the intervention group will receive Navigator support for 12 months. A Navigator is someone from the health service, who can help support your rehabilitation journey by attending therapy appointments with you, helping with any questions that you have and going through your health care information with you, such as your medication plan. Patient Navigators are a relatively new and promising role to help patients with chronic diseases and long-term conditions navigate the complexit

Participants in the intervention group will receive Navigator support for 12 months. A Navigator is someone from the health service, who can help support your rehabilitation journey by attending therapy appointments with you, helping with any questions that you have and going through your health care information with you, such as your medication plan. Patient Navigators are a relatively new and promising role to help patients with chronic diseases and long-term conditions navigate the complexities of the health care system. A non-clinical patient navigator provides practical, cultural, and emotional support to individuals throughout their rehabilitation journey, helping them overcome system barriers, coordinate services, and stay engaged in their care. By acting as a consistent point of connection between the patient, their family, and the wider care team, the navigator ensures that the rehabilitation pathway feels more accessible, supported, and tailored to the person’s needs. Aboriginal and Torres Strait Islander patients with chronic disease who are inpatients at the Royal Adelaide Hospital in South Australia will be invited to take part in the study. Eligible participants will be randomised in a 1:1 ratio to receive a 12-month program of Navigator support (intervention) or usual care (control group). Participants assigned to the intervention group will receive additional ongoing support in the form of coordinated care for their rehabilitation throughout the 12-month post-discharge period. Throughout the year, everyone will receive usual care and treatment appropriate to their chronic condition. Usual pathways of care for each individual, including multi-disciplinary rehabilitation program content, is guided by the associated clinical care Standards and Guidelines for each chronic condition in the areas of cardiac, stroke, Type 2 Diabetes-related foot complications and Type 2 Diabetes-related renal complications. All care required, whether physical, social or emotional is to be determined and discussed between the participant and their treating general practitioner, rehabilitation care providers and/or treating physician/s. Navigators will support participants to implement their individual rehabilitation plans, through care coordination including education; engagement with health care system navigation; promote patient understanding of their rehabilitation plan and work with participants and care providers to improve access and address barriers affecting access or adherence. Participants in the Navigator support (intervention) group will receive additional support and care coordination of their personalised rehabilitation program over and above the usual pathways of care. Participants in the Intervention group will be supported by rehabilitation care Navigators to assist implementation of their individual rehabilitation care plan, with additional ad-hoc support as required throughout the 12 month intervention period and reviews to occur as follows: first consultation prior to discharge from hospital, with the second consultation occurring within the first month post-discharge, then consultations at 3 months, 6 months and 12 months. Participants in the intervention group will have study visits and complete questionnaires at baseline (in-hospital), at 2 weeks, 3 months, 6 months and 12 months. Participant visits will be conducted face-to-face, online or by phone as needed. Navigator activity logs will be utilised to measure occasions and mode of service provided by the Navigator. All participants will receive updates through a regular newsletter. Optional activities in the project include participation in focus groups and/or interviews during the study and/or after participation in the study.

Sponsors

South Australian Health & Medical Research Institute
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Self-identify as Aboriginal and/or Torres Strait Islander 2. Age 18 years or over 3. Able to provide informed consent 4. Inpatient at the Royal Adelaide Hospital with one or more of the following chronic conditions: i) Coronary Artery Disease or Heart Failure ii) Stroke (ischemic stroke, intracerebral haemorrhage or subarachnoid haemorrhage) iii) Type 2 Diabetes-related Foot complications: below, through or above knee amputation, midfoot (minor) amputation, toe(s) amputation for diabetes, toe (1-5 toes) or ray amputation iv) Type 2 Diabetes-related Renal complications: estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m^2 and not on renal replacement therapy 5. Individuals for whom their clinical team deem specialised rehabilitation to be most appropriate 6. Usual place of residence geographically located in one of the participating areas

Exclusion criteria

1. Unable to give informed consent 2. Participation in the study is considered inappropriate for the patient at this time

Outcome results

None listed

Source: ANZCTR · Data processed: May 16, 2026